For effects of JWA or BRCA1 mRNA expression on survival of ESCC in terms with regimens, the synergistic effects of the two gene expression on cisplatin or docetaxel-based treatments were further explored. This evidence concerns the gene ARL6IP5 and esophageal squamous cell carcinoma.